Atticus Wealth Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15
| Closed | -$1.21K | – | 527 |
|
|
2024
Q2 | $1.21K | Hold |
15
| – | – | ﹤0.01% | 482 |
|
|
2024
Q1 | $1.2K | Hold |
15
| – | – | ﹤0.01% | 503 |
|
|
2023
Q4 | $1.19K | Hold |
15
| – | – | ﹤0.01% | 506 |
|
|
2023
Q3 | $1.05K | Sell |
15
-5
| -25% | -$350 | ﹤0.01% | 535 |
|
|
2023
Q2 | $1.44K | Hold |
20
| – | – | ﹤0.01% | 516 |
|
|
2023
Q1 | $1.23K | Sell |
20
-1,000
| -98% | -$61.7K | ﹤0.01% | 492 |
|
|
2022
Q4 | $78.7K | Sell |
1,020
-80
| -7% | -$6.17K | 0.03% | 202 |
|
|
2022
Q3 | $42K | Hold |
1,100
| – | – | 0.02% | 252 |
|
|
2022
Q2 | $42K | Sell |
1,100
-100
| -8% | -$3.82K | 0.02% | 274 |
|
|
2022
Q1 | $50K | Buy |
1,200
+300
| +33% | +$12.5K | 0.02% | 249 |
|
|
2021
Q4 | $34K | Hold |
900
| – | – | 0.01% | 268 |
|
|
2021
Q3 | $30K | Buy |
+900
| New | +$30K | 0.01% | 283 |
|